ESPR vs MSFT: Which Stock is Better?

Side-by-side comparison of Esperion Therapeutics Inc and Microsoft Corporation in 2026

Comparison Updated:

ESPR

Esperion Therapeutics Inc

$3.18

MSFT

Microsoft Corporation

$499.32

Key Metrics Comparison

MetricESPRMSFTWinner
Market Cap$816.89M$3.71TMSFT
P/E RatioN/A33.89MSFT
EPS (TTM)$N/A$14.08MSFT
Revenue Growth69.1%18.4%ESPR
Gross Margin0.0%67.9%MSFT

Analyze ESPR

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ESPR or MSFT a better investment?

Comparing ESPR and MSFT: Esperion Therapeutics Inc has a market cap of $816.89M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ESPR and MSFT?

ESPR (Esperion Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ESPR or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ESPR or MSFT?

ESPR has higher revenue growth at 69.1% vs 18.4% for MSFT.

Which company is more profitable: ESPR or MSFT?

Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for ESPR.

Which is the larger company: ESPR or MSFT?

Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $816.89M for ESPR.

Should I buy ESPR or MSFT in 2026?

Both ESPR and MSFT have investment merit. ESPR trades at $3.18 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ESPR and MSFT stock?

Key differences: Market Cap ($816.89M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (69.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).

Should I buy ESPR or MSFT in 2026?

The choice between ESPR and MSFT depends on your investment goals. ESPR shows higher revenue growth (69.1%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.

What is the market cap comparison between ESPR and MSFT?

ESPR (Esperion Therapeutics Inc) has a market cap of $816.89M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.

Popular Stock Comparisons